Picture of Heidelberg Pharma AG logo

HPHA — Heidelberg Pharma AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Wilex: US-Patent Office granted patent for amatoxin conjugates for tumour therapy

Feb 2 (Reuters) - Wilex AG  WL6G.DE : 
    * US-Patent Office granted patent for amatoxin conjugates for tumour therapy 
    * Grant of patent strengthens proprietary ADC technology of subsidiary Heidelberg Pharma 
 
Source text for Eikon:  ID:nEQ3l09sga  
Further company coverage:  WL6G.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))

Recent news on Heidelberg Pharma AG

See all news